Loading

Becoming an Early Innovation Partner of Choice

June 04, 2024
Breakout Session
Business Development and Investment
29AB
How can early-stage biotech’s position themselves as attractive prospects for collaborations, licensing, investments, or acquisitions in today’s discerning market? How can global pharmaceutical companies differentiate their offering to find the right partner to advance their next big breakthrough? Hear what leading innovation experts look for in a partner, learn from recent collaborations and explore creative approaches to stand out as ‘the’ partner of choice.
Speakers
David Kane, PhD
Managing Partner
Arc Bio Communications
Speakers
Helena Chaye, PhD
CEO
KaliVir
Anna Chen, PhD
Principal
Frazier Life Sciences
Olga Granaturova
Co-Founder/President
PriveBio
Peter Sandor, MD
Head of Corporate Strategy
Astellas Pharma Inc
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS